gsk news - Search News

Index seen higher, GSK in $2.2bn Zantac settlement

Reuters on MSN · 21m

GSK surges 6.5% after $2.2 billion Zantac lawsuits settlement

Shares of GSK rose as much as 6.5% on Thursday after the British drugmaker agreed to pay up to $2.2 billion to settle lawsuits in the United States that claimed its discontinued heartburn drug Zantac caused cancer.

Hosted on MSN · 1h

GSK Rises After Settling Zantac Cases for Up to $2.2 Billion

GSK Plc shares surged after the UK pharma company agreed to pay as much as $2.2 billion to resolve about 80,000 US court cases alleging that its old reflux medication Zantac was contaminated with a suspected carcinogen.

MarketWatch on MSN · 27m

GSK settles vast majority of Zantac claims for $2.2 billion

The British drugmaker reached a $2.2 billion settlement to resolve around 80,000 lawsuits over claims its Zantac heartburn remedy causes cancer

GSK, European Stocks

Bloomberg L.P. · 2h

European Stocks Edge Higher Ahead of US Data; GSK Shares Jump

European stocks rose on Thursday as investors awaited key US inflation data, with the healthcare sector leading gains after GSK Plc shares surged.

Reuters on MSN · 21m

European stocks slip ahead of US inflation data, GSK jumps

By Paolo Laudani and Sruthi Shankar (Reuters) -European shares slipped on Thursday, with technology and mining stocks leading losses, while investors looked out U.S. inflation data for hints on the Federal Reserve's next policy easing moves.

Republic Business on MSN · 8h

LIVE: US markets rise after Fed minutes, inflation data and earnings in focus

Ratan Tata passes away at 86 in MumbaiRatan Tata, Chairman emeritus of Tata Sons is reported to have died according to the news agency PTI. Confirming the development Tata Group issued a statement revealing that he was under critical condition and was receiving intensive care in the

2h

FTSE 100 opens higher on GSK boost

The UK's benchmark FTSE 100 opened higher on Thursday, led by gains in GSK following the settlement of lawsuits in the United ...

27m

Citi Keeps Their Buy Rating on GlaxoSmithKline (GSK)

Citi analyst Peter Verdult maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £19.00. The ...

10hon MSN

Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday

Thanks largely to news of a crucial legal settlement, GSK (NYSE: GSK) was one of the better-performing big pharma stocks on ...

2h

European stocks edge up ahead of US inflation data, GSK jumps

European stocks inched higher on Thursday, tracking Asian peers on hopes of more stimulus in China, while investors awaited U ...

GSK RSV vaccine data suggest protection across 3 seasons

The protection also held across different strains, for people in their 70s, and for those with underlying medical conditions.

GlobalData on MSN14h

GSK reports positive findings from Phase III RSV vaccine trial

The vaccine demonstrated efficacy across different respiratory syncytial virus (RSV) subtypes in older adults between the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results